banner
Epigenetic reader domain inhibitor GSK1324726A, Purity ≥98%
Inquiry

Cat. No.: X24-05-ZQ453

Epigenetic reader domain inhibitor GSK1324726A, Purity ≥98%

Synonym: 1300031-52-0; I-BET726; GSK 1324726A; GSK-1324726A; I-BET 726; I-BET726; Epigenetic reader domain inhibitor

  • CAS Number: 1300031-52-0
  • Compound CID: 52912222
img
Product Size
5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
GSK1324726A, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD2, BRD3, and BRD4.
Molecular Weight
434.91
Molecular Formula
C25H23ClN2O3
Targets
BRD2: 41 nM; BRD3: 31 nM; BRD4: 22 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 77 mg/mL (177.05 mM); Water: Insoluble; Ethanol: 77 mg/mL (177.05 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK1324726A can be used to research the therapeutic implications of BET bromodomain inhibition in oncology.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0